Itamar acquires Spry Health to expand sleep apnoea diagnostics

Itamar Medical a medical device and digital health company focussed on the integration of sleep apnoea management into the cardiac patient care pathway, has entered into a definitive agreement to acquire technology and assets of Spry Health for an undisclosed cash amount. 

Spry, based in the San Francisco Bay area, develops a wrist based medical grade remote patient monitoring (RPM) solutions.

Gilad Glick, president and chief executive officer of Itamar Medical, said: “As we sought opportunities to build on our vision of expanding sleep apnoea diagnostics from a single-night test to continuous remote patient monitoring, we identified the technology commercialised by Spry Health as a perfect fit. The acquisition of their FDA-cleared, wrist-worn technology and the addition of a knowledgeable pool of selected talented engineers, led by Spry co-founder and CTO Elad Ferber, provides an excellent platform for us to jump start our development initiatives to bring to market a continuous sleep apnoea monitoring device to further support chronic disease management, particularly as it contributes to the added burden on cardiovascular disease.

“While finger-based monitoring yields the highest accuracy, it is currently not suitable for longer-term wear. A device that is designed for the wrist, while potentially less accurate for precise disease diagnostics, is more suitable for monitoring the continuous accumulated burden of sleep apnoea and its potential impact on other diseases, such as cardiovascular conditions, due to its wearability over weeks or months.”

Spry’s technology is delivered through a watch-like home-based monitoring medical device called the Loop System. The Loop System is FDA-cleared and based on a set of sensing technologies and algorithms that contextualise real-time, continuous physiologic data to flag signs of patient deterioration using bio-markers such as SpO2, respiration rate, and heart rate.